Human LMP7/PSMB8 quantitates human LMP7/PSMB8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LMP7/PSMB8.
Human LMP7/PSMB8 quantitates human LMP7/PSMB8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human LMP7/PSMB8.
Proteasome is a multicatalytic proteinase complex with a highly ordered 20S ring-shaped nucleus structure. The structure of the nucleus is composed of 4 rings of 28 non-identical subunits; 2 rings consist of 7 alpha subunits and 2 rings consist of 7 beta subunits. Proteasomas are distributed in eukaryotic cells at a high concentration and cleave peptides in a process dependent on ATP/ubiquitin in a non-lysosomal pathway. An essential function of a modified proteasome, immunoproteasome, is the treatment of Class I MHC peptides. This gene encodes a member of the proteasome type B family, also known as the T1B family, which is a 20S nucleus beta subunit. This gene is located in the Class II region of MHC (major histocompatibility complex). The expression of this gene is induced by gamma interferon and this genetic product replaces catalytic subunit 3 (beta proteinasome subunit 5) in immunoproteasoma. Proteolytic transformation is required to generate a mature subunit. Two alternative transcripts coding two isoforms were identified; the two isoforms were treated to produce the same mature subunit.
Sensitivity
Sensitivity of the dosage: 2.2 ng/ml.
Measurement range
Dose range: 2.2 to 500 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17114603 |
| Specifications |
| Accession number | ALDD; D6S216; D6S216E; DAAP-57C1.3; JMP; large multifunctional protease 7; LMP7; Lmp-7; low molecular mass polypeptide 7; low molecular mass protein 7; low molecular weight protein 7; macrobread subunit C13; Mc13; MC13 (LMP7); MGC1491; subunit of |
| Dose range | 2.2 to 500 pg/ml |
| Sensitivity of the dosage | 2.2 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P28062 |
| Gene symbol(s) | Psmb8 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | Use exclusively for research |
| Target | PSMB8 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 µl; serum, 50 µl; plasma, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH303RB |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.